Merck & Co., Inc.MRKNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank18
Year-over-Year Change
Year-over-year net income growth rate
Latest
-48.78%
↓ 173% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-17.90%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -48.78% |
| Q3 2025 | 30.68% |
| Q2 2025 | -12.84% |
| Q1 2025 | 35.69% |
| Q4 2024 | 18.56% |
| Q3 2024 | -42.13% |
| Q2 2024 | 14.55% |
| Q1 2024 | 488.42% |
| Q4 2023 | -125.84% |
| Q3 2023 | 179.41% |
| Q2 2023 | -311.80% |
| Q1 2023 | -6.50% |
| Q4 2022 | -7.11% |
| Q3 2022 | -17.65% |
| Q2 2022 | -8.49% |
| Q1 2022 | 14.69% |
| Q4 2021 | -17.71% |
| Q3 2021 | 195.60% |
| Q2 2021 | -51.40% |
| Q1 2021 | 251.81% |
| Q4 2020 | -171.20% |
| Q3 2020 | -2.03% |
| Q2 2020 | -6.74% |
| Q1 2020 | 36.63% |
| Q4 2019 | 23.93% |
| Q3 2019 | -28.80% |
| Q2 2019 | -8.40% |
| Q1 2019 | 59.55% |
| Q4 2018 | -6.31% |
| Q3 2018 | 14.24% |
| Q2 2018 | 131.93% |
| Q1 2018 | 170.36% |
| Q4 2017 | -1767.86% |
| Q3 2017 | -102.88% |
| Q2 2017 | 25.47% |
| Q1 2017 | 360.67% |
| Q4 2016 | -127.24% |
| Q3 2016 | 81.24% |
| Q2 2016 | 7.11% |
| Q1 2016 | 15.15% |